EU begins real-time review of AstraZeneca COVID-19 antibody cocktail

by Reuters
Thursday, 14 October 2021 12:08 GMT

Oct 14 (Reuters) - The European Union's medicines regulator said on Thursday it has started a real-time review of AstraZeneca's antibody-based COVID-19 therapy after the combination medicine showed success in treating and preventing severe illness. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Arun Koyyur)

Our Standards: The Thomson Reuters Trust Principles.